Basic amino acid residues in the V3 loop of simian immunodeficiency virus envelope alter viral coreceptor tropism and infectivity but do not allow efficient utilization of CXCR4 as entry cofactor

Virology

Volumn 284, Issue 2, 2001, Pages 287-296

  Meister, Silke ^a   Otto, Claas ^a   Papkalla, Armin ^a   Krumbiegel, Mandy ^a   Pöhlmann, Stefan ^a   Kirchhoff, Frank ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; VIRUS PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMINO ACID SUBSTITUTION; ARTICLE; GENE EXPRESSION; GENE MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIMIAN IMMUNODEFICIENCY VIRUS; TARGET CELL; VIRION; VIRUS CELL INTERACTION; VIRUS ENVELOPE; VIRUS INFECTION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 2; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0035811152     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2001.0852     Document Type: Article

References (59)

1. CC-CKR5: A RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophagetropic HIV-1
2. Human immunodeficiency virus type 1 envelope glycoprotein molecules containing membrane fusion-impairing mutations in the V3 region efficiently undergo soluble CD4-stimulated gp120 release
3. Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease
4. HIV-1 induced cell fusion is mediated by multiple regions within both the viral envelope and the CCR5 coreceptor
5. Chemokine receptors and human immunodeficiency virus infection
6. Promiscuous use of CC and CXC chemokine receptors in cell-to-cell fusion mediated by a human immunodeficiency virus type 2 envelope protein
7. Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry
8. Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: A comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac
9. Natural infection of a homozygous delta 24 CCR5 red-capped mangabey with an R2b-tropic simian immunodeficiency virus
10. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
11. The V3 domain of the HIV-1 gp120 envelop glycoprotein is critical for chemokine-mediated blockade of infection
12. Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: Analysis by single amino acid substitution
13. Identification of a major co-receptor for primary isolates of HIV-1
14. Expression cloning of new receptors used by simian and human immunodeficiency viruses
15. Use of SIV for AIDS research
16. Unwelcome guests with master keys: How HIV uses chemokine receptors for cellular entry
17. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors
18. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
19. Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains
20. Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins
21. Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection
22. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
23. Human infection by genetically diverse SIVSM-related HIV-2 in west Africa
24. Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs
25. Shared antigenic epitopes of the major core proteins of human and simian immunodeficiency virus isolates
26. Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor
27. HIV type I envelope determinants for use of the CCR2b, CCR3, STRL33, and APJ coreceptors
28. Small amino acid changes in the V3 loop of human immunodeficiency virus type 2 determines the coreceptor usage for CXCR4 and CCR5
29. SIV infection of macaques as a model for AIDS pathogenesis
30. Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus
31. Coreceptor specificity of temporal variants of simian immunodeficiency virus Mne
32. The "V3" domain is a determinant of simian immunodeficiency virus cell tropism
33. SIVmac variants with differential T-cell and macrophage tropism use CCR5, and an unidentified co-factor expressed in CEMx174 cells for efficient entry
34. CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immuno-deficiency virus type 1
35. Utilization of C-C chemokine receptor 5 by the envelope glycoproteins of a pathogenic simian immunodeficiency virus, SIVmac239
36. The function of simian chemokine receptors in the replication of SIV
37. Co-receptors for HIV-1 entry
38. Complex determinants of macrophage tropism in env of simian immunodeficiency virus
39. Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage
40. Genetically divergent strains of human immunodeficiency virus type 2 use multiple coreceptors for viral entry
41. Simian immunodeficiency viruses of diverse origin can use CXCR4 as a coreceptor for entry into human cells
42. Analysis of mutations in the V3 domain of gp160 that affect fusion and infectivity
43. BOB/GPR15 coreceptor usage has no significant effect on replication of simian immunodeficiency virus in vivo
44. Simian immunodeficiency virus utilizes human and sooty mangabey but not rhesus macaque STRL33 for efficient entry
45. Mini reverse transcriptase (RT) assay
46. Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses
47. Changes in the extracellular envelope glycoprotein of variants that evolve during the course of simian immunodeficiency virus SIVMne infection affect neutralizing antibody recognition, syncytium formation, and macrophage tropism but not replication, cytopathicity, or CCR-5 coreceptor recognition
48. The simian immunodeficiency virus mnd(GB-1) strain uses CXCR4, not CCR5, as coreceptor for entry in human cells
49. Expression and coreceptor activity of STRL33/Bonzo on primary peripheral blood lymphocytes
50. Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1
51. Usage of the coreceptors CCR-5, CCR-3, and CXCR-4 by primary and cell line-adapted human immunodeficiency virus type 2
52. G protein-coupled receptors in HIV and SIV entry: New perspectives on lenti-virus-host interactions and on the utility of animal models
53. Evolution of syncytium-inducing and nonsyncytium-inducing biological virus clones in relation to replication kinetics during the course of human immunodeficiency virus type 1 infection
54. Indicator cell lines for detection of primary strains of human and simian immunodeficiency viruses
55. Adaptation to promiscuous usage of CC and CXC-chemokine coreceptors in vivo correlates with HIV-1 disease progression
56. Chemokine coreceptor usage by diverse primary isolates of human immunodeficiency virus type 1
57. Use of coreceptors other than CCR5 by non-syncytium-inducing adult and pediatric isolates of human immunodeficiency virus type 1 is rare in vitro
58. Will multiple coreceptors need to be targeted by inhibitors of human immunodeficiency virus type 1 entry?
59. Use of inhibitors to evaluate coreceptor usage by simian and simian/human immunodeficiency viruses and human immunodeficiency virus type 2 in primary cells